Protein-Antibody Conjugates (PACs): A Major Breakthrough in Cancer Research
Recently, a team of scientists from the University of Massachusetts (U.S.) engineered a nanoparticle that has the potential to revolutionize treatment of ailments like cancer and many other incurable diseases.
- This new research combines two different approaches to drug delivery - biologics and antibody-drug conjugates (ADCs) - to produce nanoparticles called protein-antibody conjugates (PACs) that can be used for precise and effective targeted drug delivery to the specific affected cells.
Biologics
- Biologics are products isolated from various natural sources - human, animal, or microorganisms and represent a promising approach to drug delivery.
- Biologics can be composed of proteins, sugars, or nucleic acids ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Strengthening Food Security and Nutrition for an Inclusive India
- 2 Protecting Children in the Digital Age: The Need for Safer Social Media
- 3 India's Bioeconomy Blueprint: NITI Aayog's Roadmap to 2035
- 4 Vision Document on Drug Control
- 5 India's Rural Credit System: Expanding Financial Inclusion and Agricultural Growth
- 6 AI in India's Judicial System: Balancing Innovation with Constitutional Values
- 7 India’s Seaward Foreign Policy: Securing Maritime Interests in a Changing World
- 8 Fast Track Courts: Strengthening the Integrity of Public Examinations
- 9 Strategic Roadmap for Making Ayurveda Global
- 10 The Growing Threat of Antimicrobial Resistance in India
